Form 4: Alumis Director Lynn Tetrault Granted 49,800 Stock Options

Alumis Inc. Director Lynn A. Tetrault was granted 49,800 stock options with an exercise price of $4.10 per share, vesting over time and upon certain events.

Summary

• Lynn A. Tetrault, a Director of Alumis Inc. (ALMS), was granted 49,800 stock options.
• The options have an exercise price of $4.10 per share.
• The grant date for these options was July 30, 2025.
• The options are set to expire on July 29, 2035.
• Vesting of the options will occur on the first anniversary of the grant date (July 30, 2026) or fully on the date of the Issuer's 2026 annual stockholder meeting, provided continuous service is maintained.
• Full vesting will also occur upon a Change in Control, subject to the Reporting Person's continuous service through such date.

Sentiment

Score: 7

Explanation: The grant of stock options to a director is a positive signal of alignment between management and shareholder interests, and a standard compensation practice. It does not indicate any negative operational or financial news.

Positives

• The granting of stock options to a director aligns their financial interests with those of shareholders, incentivizing long-term company performance.
• The structured vesting schedule encourages continued service and commitment from the director, contributing to leadership stability.

Future Outlook

This filing does not contain forward-looking statements regarding the company's financial performance or strategic direction, focusing solely on the terms and future vesting of the granted stock options.

Industry Context

This filing represents a routine insider transaction, reflecting standard compensation practices for directors in publicly traded companies. Such grants are common mechanisms to align the interests of company leadership with those of shareholders, incentivizing long-term value creation.

Comparison to Industry Standards

• Granting stock options to directors is a widely accepted practice across various industries, including biotechnology, to incentivize performance and align interests.
• The specific number of options and exercise price would typically be evaluated against compensation benchmarks for directors in similar-sized companies within the biotech sector, but this filing does not provide sufficient context for a detailed comparative analysis.

Corporate Governance

Related Party Transactions

• The stock option grant to a director is a related party transaction, which is a standard and disclosed form of executive compensation.

Stakeholder Impact

• Shareholders: The grant aligns the director's interests with shareholders, potentially leading to better long-term performance. Future dilution from option exercise is a standard consideration for equity compensation.

Next Steps

• Vesting of 49,800 stock options on the first anniversary of the grant date (July 30, 2026) or the 2026 annual stockholder meeting, subject to continuous service.
• Potential exercise of stock options by Lynn A. Tetrault before the expiration date of July 29, 2035.

Key Dates

Recommendation

This Form 4 filing details a routine stock option grant to a director, which is a standard compensation practice aimed at aligning interests. It does not contain new material information regarding the company's financial performance, strategic direction, or operational outlook that would warrant a change in investment recommendation. Investors should continue to hold based on their existing analysis of Alumis Inc.'s fundamentals and market position.

Keywords

Alumis Inc., ALMS, SEC Form 4, Stock Option Grant, Director Compensation, Equity Incentive Plan, Lynn Tetrault, Insider Transaction, Beneficial Ownership